Information on the deposit of
biological materials in depositories is required for (a) the United
States Patent and Trademark Office (USPTO) determination of
compliance with 35 U.S.C. 2(b)(2) and 112, and 37 CFR 1.801-1809,
where inventions sought to be patented rely on biological material
subject to the deposit requirements, including notification to the
interested public on where to obtain samples of deposits; and (b)
in compliance with 37 CFR 1.803 to demonstrate that the
depositories are qualified to store and test the biological
material submitted to them under patent application.
The USPTO estimates that this
information collection will receive 50 more annual responses (for
the deposits of biological materials activity, in particular) over
the 3-year period covered by this renewal request. This adjustment
caused the number of burden hour to increase by 50 hours. In
addition, this adjustment, along with increased estimated hourly
rates, caused the annual cost burden to increase by $148,593.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.